Long-term outcomes of upfront surgery in patients with resectable pathological N2 non-small-cell lung cancer
Volume: 58, Issue: 1, Pages: 59 - 69
Published: Mar 10, 2020
Abstract
OBJECTIVES Although the standard treatment for pathological N2 (pN2) non-small-cell lung cancer (NSCLC) patients is definitive chemoradiation, surgery can be beneficial for resectable pN2 disease. Herein, we report the long-term clinical outcomes of upfront surgery followed by adjuvant treatment for selected patients with resectable pN2 disease. METHODS We performed a retrospective analysis of clinical outcomes for patients with pN2 disease who...
Paper Details
Title
Long-term outcomes of upfront surgery in patients with resectable pathological N2 non-small-cell lung cancer
Published Date
Mar 10, 2020
Volume
58
Issue
1
Pages
59 - 69
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History